Abstract
Purpose of Review: To highlight emerging adjunctive neuroprotective agents for treatment of hypoxic ischemic encephalopathy (HIE). Summary: HIE is a common cause of neonatal neurologic morbidity and mortality. Therapeutic hypothermia is a standard therapy, but neuroprotection is incomplete. There are several potential adjunctive agents that can be used to augment neuroprotection when combined with hypothermia. Recent Findings: Several recent studies have evaluated the use of adjunctive therapies that, when used in combination with therapeutic hypothermia, may improve short- and long-term outcomes.
| Original language | English |
|---|---|
| Pages (from-to) | 189-193 |
| Number of pages | 5 |
| Journal | Current Pediatrics Reports |
| Volume | 8 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2020 |
Keywords
- Cooling
- HIE
- Hypothermia
- Neuroprotection
- Seizure
Fingerprint
Dive into the research topics of 'Adjunctive Neuroprotective Therapies for Treatment of Hypoxic-Ischemic Encephalopathy (HIE)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver